Theorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trials

Autori

  • Simona Fanni

DOI:

https://doi.org/10.15168/2284-4503-302

Parole chiave:

Clinical trials, African Union, NEPAD Agency, Pharmaceutical market, Pharmaceutical corporations

Abstract

This study focuses on clinical trials in Africa and suggests that a human rights-based and biolegal approach is a viable solution for ensuring effective protection and for promoting the freedom of research, ethical experimentation and the equitable enjoyment of the benefits of scientific progress, and for ensuring availability and accessibility of drugs at fair conditions. International cooperation within the African Union and the NEPAD Agency is advanced as the appropriate framework for debate and mediation between divergent positions, by relying on helpful international instruments and promoting justiciability, especially through the African Court on Human and Peoples’ Rights.

##submission.downloads##

Pubblicato

2018-03-01

Come citare

1.
Fanni S. Theorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trials. BioLaw [Internet]. 1 marzo 2018 [citato 29 marzo 2024];(1):275-319. Available at: https://teseo.unitn.it/biolaw/article/view/1283

Fascicolo

Sezione

Saggi